MS Therapy Consensus Group position statement on DMTs for MS on: September 11, 2021, 09:48:44 pm #1 From Therapeutic Advances in Neurological Disorders (August 17, 2021), "Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)":https://journals.sagepub.com/doi/full/10.1177/17562864211039648 Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
